comparemela.com

Latest Breaking News On - Edgewise therapeutics - Page 1 : comparemela.com

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares Acquired by Parkman Healthcare Partners LLC

Parkman Healthcare Partners LLC increased its holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 37.7% during the 4th quarter, HoldingsChannel reports. The fund owned 651,625 shares of the company’s stock after acquiring an additional 178,313 shares during the quarter. Parkman Healthcare Partners LLC’s holdings in Edgewise Therapeutics were worth $7,129,000 as of its […]

China
Canada
Kevin-koch
Piper-sandler
R-michael-carruthers
Corton-capital-inc
Edgewise-therapeutics-inc
Royal-bank
China-universal-asset-management-co
Nasdaq
Edgewise-therapeutics-company-profile
Parkman-healthcare-partners

Parkman Healthcare Partners LLC Boosts Stock Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)

Parkman Healthcare Partners LLC grew its holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 37.7% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 651,625 shares of the company’s stock after buying an additional 178,313 shares during the quarter. Parkman Healthcare […]

Canada
Piper-sandler
Johnr-moore
R-michael-carruthers
Edgewise-therapeutics-company-profile
Parkman-healthcare-partners
Exchange-commission
Nasdaq
Sectoral-asset-management-inc
Frazier-life-sciences-management
Jump-financial
Edgewise-therapeutics-inc

Frazier Life Sciences Management L.P. Boosts Stock Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)

Frazier Life Sciences Management L.P. lifted its holdings in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 214.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,667,203 shares of the company’s stock after buying an additional 1,818,181 shares during the […]

New-york
United-states
Canada
Behrad-derakhshan
Piper-sandler
R-michael-carruthers
Edgewise-therapeutics-company-profile
Nasdaq
Exchange-commission
Frazier-life-sciences-management
York-state-common-retirement-fund
Sg-americas-securities

Viking, CRISPR, Cytokinetics are M&A targets: Wells Fargo

Viking, CRISPR, Cytokinetics are M&A targets: Wells Fargo
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Moonlake-immunotherapeutics
Arcutis-biotherapeutics
Zealand-pharma
Verona-pharma
Bridgebio-pharma
Mohit-bansal
Neurocrine-biosciences
Iovance-biotherapeutics
Wells-fargo
Alnylam-pharmaceuticals
Rhythm-pharmaceuticals
Apellis-pharmaceuticals

Cytokinetics Stock: How Its New Drug Could Be A Safer Version Of Bristol's Camzyos

Cytokinetics Stock: How Its New Drug Could Be A Safer Version Of Bristol's Camzyos
investors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investors.com Daily Mail and Mail on Sunday newspapers.

Bristol-myers-squibb
Bristol-myer-camzyos
Serge-belanger
Roanna-ruiz
Bristol-myers
Joseph-schwartz
Robert-blum
Needham-belanger
European-medicines-agency
Drug-administration
Lexicon-pharmaceuticals
Risk-evaluation

vimarsana © 2020. All Rights Reserved.